In Vivo Multi-Tissue Corticosteroid Microarray Time Series Available Online at Public Expression Profile Resource (PEPR)
- 4 November 2003
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 4 (6) , 791-799
- https://doi.org/10.1517/phgs.4.6.791.22816
Abstract
Gene microarrays are becoming a key tool for the analysis of changes in gene expression in a variety of conditions. Use of microarrays to analyze drug responses has mainly been restricted to comparing treated versus untreated samples at a few time points. Such data do not permit the use of another important tool, pharmacokinetic/pharmacodynamic (PK/PD) modeling. Such modeling requires the simultaneous analysis of pharmacokinetic data along with time series data on dynamic responses. This report describes data obtained from two extended microarray time series (rat liver and skeletal muscle) for the in vivo responses to a single bolus dose of methylprednisolone that are uniquely available online in a single gene query format. Use of these data does not require any a priori knowledge or software normally necessary for the analysis of microarray data. Since the pharmacokinetic data and receptor model have been published, the results are amenable to PK/PD and pharmacogenomic evaluation.Keywords
This publication has 11 references indexed in Scilit:
- DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent mannerNucleic Acids Research, 2004
- Modeling of Corticosteroid Pharmacogenomics in Rat Liver Using Gene MicroarraysThe Journal of Pharmacology and Experimental Therapeutics, 2003
- The Cannabinoid CB1 Antagonist N-Piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) Differentially Alters the Reinforcing Effects of Heroin under Continuous Reinforcement, Fixed Ratio, and Progressive Ratio Schedules of Drug Self-Administration in RatsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Diversity of Mechanism-Based Pharmacodynamic ModelsDrug Metabolism and Disposition, 2003
- Fifth-Generation Model for Corticosteroid Pharmacodynamics: Application to Steady-State Receptor Down-Regulation and Enzyme Induction Patterns During Seven-Day Continuous Infusion of Methylprednisolone in RatsJournal of Pharmacokinetics and Pharmacodynamics, 2002
- CCAAT/enhancer‐binding protein β is required for activation of genes for ornithine cycle enzymes by glucocorticoids and glucagon in primary‐cultured hepatocytesFEBS Letters, 2001
- Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.Journal of Pharmacokinetics and Pharmacodynamics, 1998
- Dose-Dependence and Repeated-Dose Studies for Receptor/Gene-Mediated Pharmacodynamics of Methylprednisolone on Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat LiverJournal of Pharmacokinetics and Biopharmaceutics, 1998
- The Glucocorticoid-responsive Gene CascadePublished by Elsevier ,1997
- Molar Quantification of Specific Messenger Ribonucleic Acid Expression in Northern Hybridization Using cRNA StandardsAnalytical Biochemistry, 1993